• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

79 个国家 COVID-19 的年龄标准化发病率、死亡率和病死率:横断面比较及其与相关因素的相关性。

The age-standardized incidence, mortality, and case fatality rates of COVID-19 in 79 countries: a cross-sectional comparison and their correlations with associated factors.

机构信息

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.

Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea.

出版信息

Epidemiol Health. 2021;43:e2021061. doi: 10.4178/epih.e2021061. Epub 2021 Sep 8.

DOI:10.4178/epih.e2021061
PMID:34525501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8611321/
Abstract

OBJECTIVES

During the coronavirus disease 2019 (COVID-19) pandemic, crude incidence and mortality rates have been widely reported; however, age-standardized rates are more suitable for comparisons. In this study, we estimated and compared the age-standardized incidence, mortality, and case fatality rates (CFRs) among countries and investigated the relationship between these rates and factors associated with healthcare resources: gross domestic product per capita, number of hospital beds per population, and number of doctors per population.

METHODS

The incidence, mortality, and CFRs of 79 countries were age-standardized using the World Health Organization standard population. The rates for persons 60 years or older were also calculated. The relationships among the rates were analysed using trend lines and coefficients of determination (R2). Pearson correlation coefficients between the rates and the healthcare resource-related factors were calculated.

RESULTS

The countries with the highest age-standardized incidence, mortality, and CFRs were Czechia (14,253 cases/100,000), Mexico (182 deaths/100,000), and Mexico (6.7%), respectively. The R2 between the incidence and mortality rates was 0.852 for all ages and 0.945 for those 60 years or older. The healthcare resources-related factors were associated positively with incidence rates and negatively with CFRs, with weaker correlations among the elderly.

CONCLUSIONS

Compared to age-standardized rates, crude rates showed greater variation among countries. Medical resources may be important in preventing COVID-19-related deaths; however, considering the small variation in fatality among the elderly, preventive measures such as vaccination are more important, especially for the elderly population, to minimize the mortality rates.

摘要

目的

在 2019 年冠状病毒病(COVID-19)大流行期间,粗发病率和死亡率已被广泛报道;然而,标化发病率更适合进行比较。本研究旨在估计和比较各国的标化发病率、死亡率和病死率(CFR),并探讨这些比率与与医疗保健资源相关的因素之间的关系:人均国内生产总值、每人口的病床数和每人口的医生数。

方法

使用世界卫生组织标准人口对 79 个国家的发病率、死亡率和 CFR 进行标化。还计算了 60 岁及以上人群的比率。使用趋势线和确定系数(R2)分析比率之间的关系。计算比率与医疗保健资源相关因素之间的 Pearson 相关系数。

结果

标化发病率、死亡率和 CFR 最高的国家分别为捷克(14253 例/100000)、墨西哥(182 例/100000)和墨西哥(6.7%)。所有年龄组的发病率和死亡率之间的 R2 为 0.852,60 岁及以上人群的 R2 为 0.945。医疗保健资源相关因素与发病率呈正相关,与病死率呈负相关,老年人之间的相关性较弱。

结论

与标化率相比,粗率在国家之间的差异更大。医疗资源可能对预防 COVID-19 相关死亡很重要;然而,考虑到老年人病死率的微小差异,预防措施(如接种疫苗)更为重要,特别是对于老年人群,以最大程度降低死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/dfee854073ad/epih-43-e2021061f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/72631c5c4691/epih-43-e2021061f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/171c1bd830be/epih-43-e2021061f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/dfee854073ad/epih-43-e2021061f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/72631c5c4691/epih-43-e2021061f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/171c1bd830be/epih-43-e2021061f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a64/8611321/dfee854073ad/epih-43-e2021061f3.jpg

相似文献

1
The age-standardized incidence, mortality, and case fatality rates of COVID-19 in 79 countries: a cross-sectional comparison and their correlations with associated factors.79 个国家 COVID-19 的年龄标准化发病率、死亡率和病死率:横断面比较及其与相关因素的相关性。
Epidemiol Health. 2021;43:e2021061. doi: 10.4178/epih.e2021061. Epub 2021 Sep 8.
2
The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal-a comparison of age-specific and age-adjusted CFRs between seven countries.新冠病毒粗病死率(CFR)令人困惑,其隐藏的信息多于揭示的信息——七个国家的年龄特异性和年龄调整后 CFR 比较。
PLoS One. 2020 Oct 21;15(10):e0241031. doi: 10.1371/journal.pone.0241031. eCollection 2020.
3
The age structure of cases as the key of COVID-19 severity: Longitudinal population-based analysis of European countries during 150 days.病例年龄结构是 COVID-19 严重程度的关键:150 天期间欧洲国家的基于人群的纵向分析。
Scand J Public Health. 2022 Aug;50(6):738-747. doi: 10.1177/14034948211042486. Epub 2021 Dec 20.
4
The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.加强针接种在降低 COVID-19 年龄调整病死率中的作用:来自 32 个国家的证据。
Front Public Health. 2023 Apr 18;11:1150095. doi: 10.3389/fpubh.2023.1150095. eCollection 2023.
5
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.各国病例年龄分布对 COVID-19 病死率的贡献:九国人口研究。
Ann Intern Med. 2020 Nov 3;173(9):714-720. doi: 10.7326/M20-2973. Epub 2020 Jul 22.
6
Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.COVID-19 病死率的性别差异-比较七个国家的年龄相关差异和一致性。
PLoS One. 2021 Apr 29;16(4):e0250523. doi: 10.1371/journal.pone.0250523. eCollection 2021.
7
Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.韩国调整年龄和性别后 COVID-19 的病死率:整个疫情期间死亡率估计风险的演变。
Int J Infect Dis. 2020 Dec;101:306-311. doi: 10.1016/j.ijid.2020.09.1478. Epub 2020 Oct 2.
8
Democracy and case fatality rate of COVID-19 at early stage of pandemic: a multicountry study.疫情早期的民主与 COVID-19 病死率:一项多国研究。
Environ Sci Pollut Res Int. 2022 Feb;29(6):8694-8704. doi: 10.1007/s11356-021-16250-x. Epub 2021 Sep 7.
9
SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.墨西哥首轮疫情过后的 SARS-CoV-2 感染病死率。
Int J Epidemiol. 2022 May 9;51(2):429-439. doi: 10.1093/ije/dyac015.
10
COVID-19 in the Eastern Mediterranean Region: testing frequency, cumulative cases and mortality analysis.中东呼吸综合征冠状病毒(MERS-CoV):测试频率、累计病例和死亡率分析。
East Mediterr Health J. 2020 Sep 24;26(9):1005-1010. doi: 10.26719/emhj.20.110.

引用本文的文献

1
Determinants of COVID-19 severity and mortality in children: A retrospective and multicenter cohort study in Medan, Indonesia.儿童新冠病毒病严重程度和死亡率的决定因素:印度尼西亚棉兰的一项回顾性多中心队列研究。
Narra J. 2024 Aug;4(2):e865. doi: 10.52225/narra.v4i2.865. Epub 2024 Aug 8.
2
Should we ignore SARS-CoV-2 disease?我们是否应该忽视 SARS-CoV-2 疾病?
Epidemiol Infect. 2024 Mar 20;152:e57. doi: 10.1017/S0950268824000487.
3
Occurrence of COVID-19 and serum - and polyfluoroalkyl substances: A case-control study among workers with a wide range of exposures.

本文引用的文献

1
Impact of COVID-19 on older adults and role of long-term care facilities during early stages of epidemic in Italy.COVID-19 对老年人的影响以及意大利疫情早期长期护理机构的作用。
Sci Rep. 2021 Jun 15;11(1):12530. doi: 10.1038/s41598-021-91992-9.
2
COVID-19 mortality needs age adjusting for international comparisons.为了进行国际比较,新冠病毒疾病(COVID-19)死亡率需要进行年龄调整。
J Med Virol. 2021 Jul;93(7):4127-4129. doi: 10.1002/jmv.27007. Epub 2021 Apr 23.
3
Are Nursing Homes COVID-19's "Contaminated Wells," and Will They Receive Additional Resources?
新型冠状病毒肺炎与血清及多氟烷基物质的关联:一项针对广泛暴露人群的病例对照研究。
Glob Epidemiol. 2024 Jan 7;7:100137. doi: 10.1016/j.gloepi.2024.100137. eCollection 2024 Jun.
4
Regional Variations in Coronavirus Disease 2019 Mortality in Japan: An Ecological Study.日本2019冠状病毒病死亡率的地区差异:一项生态学研究。
JMA J. 2023 Oct 16;6(4):397-403. doi: 10.31662/jmaj.2023-0052. Epub 2023 Sep 27.
5
Topic and Trend Analysis of Weibo Discussions About COVID-19 Medications Before and After China's Exit from the Zero-COVID Policy: Retrospective Infoveillance Study.微博关于 COVID-19 药物的讨论在我国结束“动态清零”政策前后的主题和趋势分析:回顾性信息监测研究。
J Med Internet Res. 2023 Oct 27;25:e48789. doi: 10.2196/48789.
6
Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates.对21个国家的新冠病毒疾病病死率进行时间序列比较,并对多个协变量进行调整。
Osong Public Health Res Perspect. 2022 Dec;13(6):424-434. doi: 10.24171/j.phrp.2022.0212. Epub 2022 Nov 28.
7
Global burden of calcific aortic valve disease and attributable risk factors from 1990 to 2019.1990年至2019年钙化性主动脉瓣疾病的全球负担及归因风险因素
Front Cardiovasc Med. 2022 Nov 23;9:1003233. doi: 10.3389/fcvm.2022.1003233. eCollection 2022.
8
Cause-specific mortality in Korea during the first year of the COVID-19 pandemic.韩国在 COVID-19 大流行的第一年的特定病因死亡率。
Epidemiol Health. 2022;44:e2022110. doi: 10.4178/epih.e2022110. Epub 2022 Nov 23.
9
Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022.墨西哥 2020 年 3 月至 2022 年 8 月 COVID-19 疫情的五波比较流行病学。
BMC Infect Dis. 2022 Oct 31;22(1):813. doi: 10.1186/s12879-022-07800-w.
Am Health Drug Benefits. 2020 Sep;13(4):162-163.
4
Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.与 COVID-19 相关的超额死亡人数,按年龄、种族和族裔划分 - 美国,2020 年 1 月 26 日至 10 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527. doi: 10.15585/mmwr.mm6942e2.
5
Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病的流行病学和临床特征。
Int J Infect Dis. 2020 Sep;98:462-466. doi: 10.1016/j.ijid.2020.07.017. Epub 2020 Jul 21.
6
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.各国病例年龄分布对 COVID-19 病死率的贡献:九国人口研究。
Ann Intern Med. 2020 Nov 3;173(9):714-720. doi: 10.7326/M20-2973. Epub 2020 Jul 22.
7
Post-COVID-19 global health strategies: the need for an interdisciplinary approach.后新冠疫情全球卫生战略:跨学科方法的必要性。
Aging Clin Exp Res. 2020 Aug;32(8):1613-1620. doi: 10.1007/s40520-020-01616-x. Epub 2020 Jun 11.
8
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China.中国武汉无症状与有症状新冠肺炎患者的临床特征比较。
JAMA Netw Open. 2020 May 1;3(5):e2010182. doi: 10.1001/jamanetworkopen.2020.10182.
9
Estimating the instant case fatality rate of COVID-19 in China.估算中国 COVID-19 的即时病死率。
Int J Infect Dis. 2020 Aug;97:1-6. doi: 10.1016/j.ijid.2020.04.055. Epub 2020 Apr 24.
10
Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries.与降低新冠病毒疾病病死率相关的平缓曲线——对65个国家的生态学分析
J Infect. 2020 Jul;81(1):e98-e99. doi: 10.1016/j.jinf.2020.04.007. Epub 2020 Apr 17.